neuroprotection
2 stories
-
healthDiabetes Drugs Show Potential to Curb Dementia in Psychiatric Patients
A US Department of Veterans Affairs study finds SGLT2 inhibitors may reduce all-cause dementia risk by up to 46% in older adults with mood or psychotic disorders.
-
healthGLP-1 Drugs Show Promise in Reducing Dementia Risk for Kidney Disease Patients
New research indicates GLP-1 receptor agonists may significantly lower dementia and Alzheimer's risk in patients with chronic kidney disease and type 2 diabetes.